Comparison of the incidence of pelvic inflammatory disease in intrauterine devices users by gonorrhea and chlamydia screening strategies

Abstract

There are no uniformly accepted strategies for the timing and need for gonorrhea/chlamydia (GC/CT) screening in intrauterine device (IUD) users. The incidence of pelvic inflammatory disease (PID) in IUD users by different GC/CT screening strategies is not known. We compared the incidence of PID within 90 days after IUD insertion in women who were and were not screened for GC/CT. The hypothesis was that there were no differences in PID rates among GC/CT screening groups.